Figure S2 from The Human CD38 Monoclonal Antibody Daratumumab Shows Antitumor Activity and Hampers Leukemia–Microenvironment Interactions in Chronic Lymphocytic Leukemia
Year: 2023
Type: other
Abstract: Figure S2. Effect of all-trans retinoic acid (ATRA) on daratumumab-induced CDC.CLL cells (n=6) were treated with 10nM ATRA or left untreated for 48h. CD38 expression was analyzed subsequently (CD19-FITC CD5-PECy5 CD38PE).
Authors: Alba Matas-Céspedes, Anna Vidal-Crespo, Vanina Rodriguez, Neus Villamor, Julio Delgado, Eva Giné, Heleia Roca-Ho, Pablo Menéndez, Elías Campo, Armando López-Guillermo, Dolors Colomer, Gaël Roué, Adrian Wiestner, Paul W.H.I. Parren, Parul Doshi, Jeroen Lammerts van Bueren, Patricia Pérez-Galán
Language: English
Subfield: Genetics (clinical)
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4361913290